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Surface plasmon resonance (SPR)-based sensors enable the rapid, label-free and highly sensitive detection of a large range of
biomolecules. We have previously shown that, using silver-coated optical fibers with a high surface roughness, re-scattering of light from
the surface plasmons is possible, turning SPR into a radiative process. The efficacy of this platform has proven for the detection of large
biomolecules such as viruses, proteins and enzymes. Here, we demonstrate that by bringing together this novel emission-based fiber SPR
platform with an improved surface functionalization process aimed at properly orienting the antibodies, it is possible to rapidly and
specifically detect the regulation of human apolipoprotein E (apoE), a low-molecular-weight protein (~39 kDa) known to be involved in
cardiovascular diseases, Alzheimer's disease and gastric cancer. The results obtained clearly show that this new sensing platform has the
potential to serve as a tool for point-of-decision medical diagnostics.
From the Clinical Editor: In this study, a novel emission-based surface plasmon resonance platform using silver-coated optical fibers is
described. Properly orienting antibodies on the surface enables rapid and specific detection of human apolipoprotein E (apoE).
© 2013 Elsevier Inc.
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Open access under CC BY-NC-ND license.Surface plasmons are electromagnetic waves at the interface of
twomedia that have permittivity with opposite signs, as in the case
of a metal and a dielectric.1 Surface plasmons can be excited using
a prism-based configuration (Kretschmann and Otto
configuration),2 via a waveguide-based approach,3 or a fiber-
based architecture.4,5 All of these approaches exploit the
evanescent field at the substrate–metal interface, which resonantly
interacts with plasmons–polaritons at the metal–dielectric
interface.6 Surface plasmon resonance (SPR) is sensitive to
changes of refractive index of the dielectric, and thus can be
applied as a powerful technique for biosensing.7 In the case of a
prism-based configuration, the resonance is monitored by
collecting the reflected light as a function of the incidence angle
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Open access under CC BY-NC-ND license. at a fixed angle.8 In waveguide or optical fiber architectures, a
broadband light source is used to excite the surface plasmons, and
the transmitted light is collected and analyzed to monitor the
resonance, which appears as a dip in the spectrum.1
We have previously demonstrated that the plasmonic wave's
energy can be scattered when a rough metallic film is used and
re-emitted as light, turning SPR it into a radiative process.9 In
particular we have shown that the re-scattered light from a silver-
coated optical fiber could be used efficiently as a biosensing
platform to detect the influenza A virus. The platform offers
many advantages to more conventional SPR architectures, such
as a higher signal-to-noise ratio, the possibility to perform
fluorescence and SPR simultaneously within the same device,
and the possibility of having a reference channel on the same
fiber for reducing environmental drifts that could affect the
reliability of the device.
One challenge that faces all SPR-based sensors is that they work
best for large molecules, as in such cases a relatively small number
of molecules is required to observe a change in the SPR response,
and we have previously shown that influenza A virus (thousands of
kDa) is easily detected by the radiative-SPR platform.9e for the detection of apolipoprotein E in medical diagnostics applications.
.007
Figure 1. (A) Representation of the surface plasmon resonance biosensing architecture: the re-scattered plasmonic wave from the silver-coated optical fiber is
collected and analyzed using a compact spectrometer. (B)Measured SPR response shift versus bulk index of refraction of the water/glycerol solutions in contact
with the silver SPR probe surface. Inset shows a typical measurement of the re-scattered SPR signal.
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plays not only in ensuring the specificity of the sensor, but in
improving the detection limit and enabling it to sense relatively
small proteins. In addition, we present some improvements to the
sensor architecture, including the use of an LED source and a
simplified flow cell. Comparing two different approaches for
immobilizing the antibodies on the surface of the sensor, we
demonstrate that the detection limit can be reduced if the
antibodies are properly oriented, enabling efficient sensing and
quantification of relevant concentration of human apoE, a
relatively low-molecular-weight (~39 kDa) protein, known to be
one of the major determinants in lipid transport, playing a critical
role in arteriosclerosis and other diseases including Alzheimer's
disease.10,11 The same protein is also indicated as potential
biomarker in gastric cancer,12,13 where a significant up-
regulation of apoE mRNA occurs in patients presenting the
disease. Conventional methods for detecting apoE, such as
enzyme-linked immunosorbent assay (ELISA), are expensive in
terms of equipment needed to perform the analyses. In particular,
commercially available ELISA kits used to quantify apoE
concentrations take about 5 h before reaching a readable signal
(see technical notes from Mabtech about “ELISA for Human
Apolipoprotein E,” http://www.mabtech.com).Methods
Sensor fabrication
The SPR sensor was fabricated as reported in François et al.9
Briefly, it was fabricated from a bare core (unstructured) optical
fiber made of F2 Schott lead silicate glass with a refractive index
of 1.62 and a diameter of 130 μm. The fiber was produced in-
house by extruding a bulk glass sample into a rod and drawing
into a fiber by using a fiber drawing tower. The fiber was
subsequently coated with a polymer with a refractive index of
1.52. A short section (~4 mm) of the coating was mechanically
stripped and coated with silver using the Tollens reaction.14 A
solution of 20 mL of AgNO3 0.24 mol/L and 40 μL of KOH0.25 mol/L was reacted with a 20-mL mixture of methanol and
glucose (1.9 mol/L) 1:2, in a petri dish in the presence of the
fibers for 8 min at room temperature. After the coating, the fibers
were thoroughly rinsed in millipore water and dried in air. The
sensors were then immersed for 30 min in a 2-mg/mL
solution of poly(allylamine hydrochloride) (PAH), a posi-
tively charged polyelectrolyte that adsorbs onto the nega-
tively charged silver surface, introducing amine groups for
further bioconjugation, rinsed with millipore water and dried
under a stream of nitrogen.
Flow cell
Silver-coated fibers were mounted in a flow cell to expose the
sensor to different species under controlled flow conditions. The
flow cell used was adapted from the commercial IDEX
MicroCross product, by drilling a 600-μm hole from the top of
the piece to allow the collection of the light scattered by the
sensor. A 600-μm glass rod placed into the hole was used to seal
the flow cell. The flow cell was connected to a syringe by means
of capillary tube with an internal diameter of 150 μm and a
length of 5 cm. A syringe pump (Chemyx nanojet) connected to
the syringe was used to control the flow rate of the species inside
the flow cell. The total volume of the flow cell is in the order of
microliters (see Figure 1, A).
Optical setup
Light from a white LED (6500K, Thorlabs) was focused and
coupled into the fiber samples. In our previous work we used a
broadband halogen light source,9 now replaced with the white
LED whose emission spectrum intensity is centered in the SPR
wavelength region, reducing the background of the scattered
signal overlapping that of the emitted SPR. To some extent, this
increases the signal-to-noise ratio, thus improving the sensor
resolution15 and enabling a better detection limit. The light
scattered out from the silver-coated region was collected directly
from this region by focusing the light into a commercial optical
fiber (Ocean Optics) positioned directly under the sensing area
Figure 2. (A) Schematization of the cross-linking surface functionalization strategy: the antibodies are covalently linked to the polyelectrolyte layer. (B)
Schematization of the biotin–neutravidin functionalization strategy explored in this work: biotinylated antibodies are linked to a neutravidin layer, enabling a
proper orientation. (C) Typical real-time measured SPR response for neutravidin immobilization from a 400-nM solution.
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QE65000) (see Figure 1, A). The inset in Figure 1, B shows a
typical recorded spectrum for the re-scattered SPR signal from a
sensor immersed in millipore water.
Data analysis
The recorded scattering spectra were analyzed by means of an
in-house developed Matlab routine that performs a cross-
correlation between the spectra, and identifies the wavelength
of the cross-correlation signal by fitting with a single Gaussian
curve. The SPR position was monitored in real time during the
biosensing experiment, providing feedback during the surface
functionalization procedures as well as during the biosensing
measurements. The typical error in these measurements arises
from the approximation of the curve to be fitted with a single
Gaussian model, but the value obtained for the coefficient of
determination approached the unity.
Adsorbate quantification
The quantification of biological species adsorbed on the
sensor's surface is critical for the optimization of the surface
functionalization and together with SPR spectroscopy enables to
perform surface science studies, directly detecting adsorption
onto a surface with submonolayer sensitivity. In particular, the
adsorbate amount can be quantified from the SPR response,
assuming the dielectric properties of the metal and of the
adsorbate are known. The SPR response can be approximated as
linear over a narrow range of refractive index16:
R ¼ m neff−nsð Þ ð1Þ
where m is the sensitivity, calculated from the slope of Figure 1,
B for the range of interest (see Sensor characterization), ns is the
bulk solution refractive index and neff is the effective refractive
index of the bilayer adsorbate-bulk solution on the sensor
surface, where the thickness of the adsorbate layer is da. Since
light is used to probe this index of refraction, it is straightforwardto assume that the proper weighting factor at each point in the
bilayer structure should be proportional to the intensity of light at
that point. The evanescent electromagnetic field decays away
exponentially into this medium with a characteristic decay
length, ld, of ∼25% to 50% of the wavelength of the light.17
From the SPR response, the effective refractive index of the
liquid layer can be estimated, and used to estimate the
penetration depth (ld) of the evanescent field into the sensing
region, which comes from Maxwell's equations16:
ld ¼ λ
2πRe −n4eff= n
2
eff þ εmetal
  1
2
ð2Þ
where εmetal is the complex dielectric constant of the metal at the
SPR wavelength. ld is an estimation of the interaction depth of
the SPR with the sensing medium.
The adsorbate film thickness da, assuming it is small relative
to ld, could be calculated from the SPR response as follows
16:
d ¼ ld
2
R
m na–nsð Þ ð3Þ
where na is the bulk refractive index of the adsorbate. From the
effective adsorbate thickness and its molecular weight, the
surface coverage (ng/cm2) can be calculated16:
SC ¼ 100dapa ð4Þ
where pa is the bulk density of the adsorbate in g/cm
3. The
quantification of the surface coverage for adsorbed/bound
species on the sensor surface enables an estimate to be made
of the quality of the functionalization approach and enables
systematic optimization. The surface coverage was estimated for
each step in the functionalization process and was used to
compare the two functionalization approaches proposed here.
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Two different approaches for immobilizing anti-apoE
antibodies on the surface were compared. In the first strategy
(in the text named as cross-linking approach, see Figure 2, A), a
330 nM solution of antibody was used to link to the amine-
terminated surface in presence of 0.22 M 1-ethyl-3-(3-dimethy-
laminopropyl) carbodiimide (EDC) and 0.22 M N-hydroxysuc-
cinimide (NHS), reacting for 90 min, and the wavelength of the
emitted SPR was monitored over time. Under these experimental
conditions, the presence of the coupling agents activates any
carboxylic group present on the antibodies creating a semi-stable
amine-reactive NHS-ester that reacts with amine groups to form
a stable amide bond.18 After the immobilization of anti-apoE
antibodies, the surface was blocked with a commercial blocking
reagent (“The Blocking Solution,” Candor) overnight to reduce
non-specific binding, until no further shift in the SPR position
was observed as a means of ensuring a complete saturation of the
available functional group. The blocking reagent prevents non-
specific binding occurring and is essential in label-free
biosensing approaches, where the detection mechanism is
based on the local change of refractive index caused by the
presence of the mass of the analyte. After the passivation, the
sensor was exposed to the analyte solution.
In the second approach (referred to here as the biotin–
neutravidin strategy, see Figure 2, B), biotin (0.6 mg/mL), a
vitamin containing a carboxylic group, was covalently bound to
the amine-terminated surface of PAH in the presence of EDC
(0.2 M) and NHS (0.2 M) for about 30 min, and the SPR signal
was monitored over time. After a thorough PBS wash, the
surface was exposed for about 40 min to a 400-nM solution of
neutravidin, a tetrameric protein that binds specifically biotin,
previously immobilized, forming a strong non-covalent bond
(KD~10
−15 M).19 After a thorough PBS wash, a 330-nM
solution of biotinylated anti-apoE immunoglobulin (IgG) was
flowed for about 90 min, allowing the biotin function of
antibodies to bind to free groups on neutravidin, thanks to its
tetrameric conformation. After the immobilization of antibodies,
the sensor was exposed to the blocking solution overnight in
order to block any unreacted binding site, preventing non-
specific binding. As for the first approach, the exposure time of
the species in the flow cell was varied until no further shift in the
SPR position was observed as a means of ensuring a complete
saturation of the available functional group.Results
Sensor characterization
The performance of the sensor was characterized by exposing
the sensing region of freshly coated sensors to glycerol/water
solutions with refractive indices ranging from 1.33 to 1.47, and
measuring the SPR response. Figure 1, B shows the measured
shift in the SPR wavelength with respect to its position in water,
as a function of the refractive index. From the data in Figure 1,
B, it is possible to estimate the sensitivity of the system as a
function of refractive index. Figure 1, B demonstrates that the
sensitivity calculated as wavelength shift (S) increases withincreasing refractive index, consistently with predictions.6 For
liquids with effective refractive indices in the range 1.3–1.4,
which is relevant for aqueous environments in biological
applications, the sensitivity of the sensor is approximately
740 nm/RIU, smaller than the best-reported values for fiber
optics-based SPR sensors operating in this range.16,20
However, the limit of detection (LOD) is often reported as a
mean to measure the performance of a sensor, although it is not
an intrinsic characteristic of the sensor because it depends on the
equipment used to measure it. In the case of our platform, the
equipment and the data analysis we use, allow us to discriminate
a SPR shift (R) of 0.03 nm, calculated as three times the noise.21
LOD ¼ R
S
ð5Þ
The resulting LODof our platform fromEq. 5 is 0.4×10−4 RIU.
Such a LOD is not as good as the best-reported fiber-based SPR
sensors,20 but it is still comparable to other recently reported values
for fiber-based SPR.22,23 The reason for the poorer performance is
the high refractive index of the glass substrate used here (1.62),
which is larger than the commonly employed silica substrates
(1.45). In fact, a lower refractive index of the substrate results in
higher sensitivity.24 Numerical simulations and experimental
results we have obtained have demonstrated that a decrease of
refractive index for the fiber substrate from 1.62 (F2 glass) to
1.45 (silica) results in a sensitivity increase of at least a factor 5
(data not shown), measured by collecting the scattered plasmonic
wave. The use of lower index glasses offers a route to future
improvement of the sensor performance, with a predicted LOD of
at least 0.8×10−5 RIU, in the same order of magnitude of the
best performing optical fiber-based SPR platform.2,20
However, quantitatively speaking, we do not expect the
proposed architecture to have higher sensitivity respect to
transmission-based optical fiber SPR platform, as the intrinsic
sensitivity does not depend on the collection strategy. Some
advantage of our architecture, compared to conventional
transmission-based SPR is, as previously discussed in François
et al9 the improved SNR, the lower control needed on the
metallic coating thickness, the higher versatility in terms of the
possibility to perform fluorescence sensing based techniques
such as completing a sandwich assay within the same platform
and last but not least the capability of multiplexing, which is not
possible with transmission based SPR on the same optical fiber.
As mentioned in Adsorbate quantification, the estimation of
the sensor's sensitivity is required to enable quantification of the
number of biomolecules immobilized on the surface, as explored
further below.
Biotin–neutravidin immobilization
As described in Surface functionalization approaches, two
different functionalization strategies were tested. In one strategy,
IgGs were immobilized on the amine-terminated PAH layer by
means of cross-coupling reagents. In the other functionalization
approach, after covering the negatively charged silver film with
the positively charged PAH polyelectrolyte, biotin was covalent-
ly linked to the free amine groups on PAH, as reported in Surface
functionalization approaches neutravidin, a deglycosylated
Figure 3. (A) Kinetic measurement of the SPR response for antibody immobilization for the cross-linking approach (black line), and for the biotin–neutravidin
approach (blue line). (B) Kinetic measurement of the SPR response for 30 μg/mL human apoE sensing for the two functionalization strategies: apoE is not
detectable with the cross-linking strategy (black line), while it is clearly visible using the biotin–neutravidin approach (blue line). Inset: SPR response upon
exposure of CEA protein to the surface modified with biotin–neutravidin approach.
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biotinylated surface, and because of its affinity to biotin,
immobilized onto the surface. Note that the dissociation constant
of the pairs biotin/neutravidin is KD~10
−15 M, making it one of
the strongest non-covalent bonds known.19 Furthermore, using a
biotin-coated sensing region instead of depositing directly
neutravidin onto the sensor surface25 enables to promote a
specific orientation of the neutravidin and therefore of the
subsequent biotinylated antibodies which is quite unlikely
otherwise. In Figure 2, C is shown the measured shift of the
SPR signal overtime, upon exposure of neutravidin to the
biotinylated surface. The flow was kept constant at 10 μL/min to
avoid depletion of the neutravidin concentration around the
sensing area. From the SPR shift shown in Figure 2, C, and using
known information regarding the sensor's sensitivity, the amount
of neutravidin immobilized on the sensor can be estimated, as
explained in Adsorbate quantification. Substituting in Eq. 1 the
SPR shift of 3.5 nm (taken from Figure 2, C), the effective
refractive index can be calculated to be neff =1.341, and then used
to estimate the penetration depth at the wavelength of 550 nm,
from Eq. 2, giving a probe depth ld~165 nm. Assuming a
refractive index of 1.45 for bulk neutravidin (a typical value for
biomolecules26), from Eq. 3 the adsorbate layer thickness is
calculated to be d~3.5 nm, which corresponds well to the
physical thickness of neutravidin (5.6 nm×5 nm×4 nm).27 This
result corroborates the hypothesis that a full monolayer of
neutravidin has been deposited on the surface. In terms of surface
coverage, a value of 400 ng/cm2 is obtained from Eq. 4, which
is consistent with data obtained in literature for a densely
pack monolayer.28
After the immobilization of neutravidin on the surface,
biotinylated antibodies are loaded into the sensor and bound to
available neutravidin groups, taking advantage of the biotinfunction (see Figure 3, A, blue line), preventing any cross-
binding of the antibodies to themselves, and thus linking the
antibodies to the surfaces in a more ordered fashion. As for
neutravidin, the quantity of biotinylated antibodies linked to the
surface could be estimated from the SPR response, giving a
surface coverage of 155 ng/cm2 (assuming that the antibodies
have the same refractive index and bulk density as for
neutravidin), corresponding to approximately one immobilized
antibody for each eight neutravidins, roughly half of that obtained
with the cross-linking strategy (see Direct cross-linking).
Direct cross-linking
Considering the abundance of carboxylic groups in
biological species, the cross-linking strategy is a convenient
approach to immobilize proteins onto a surface, and this
approach has been used for antibodies.18 The main drawback
of this approach is the cross-reactivity between amine and
carboxylic groups present on other antibodies, resulting in
antibodies cross-linking, which is itself quite undesirable
because it could cause a loss of specificity and reactivity of
the IgG binding sites. Additionally the immobilized antibodies
will most likely be covalently bound with a random orientation
which will further affect their ability to capture their antigen
counterparts. Moreover, in the cross-linking approach, the SPR
shift for antibodies is sensitive to the amount of cross-linking
that occurs, and varies as a function of the relative
concentration of antibodies and coupling reagents, which can
raise issues of control and reproducibility of the reaction. In
order to perform a reasonable comparison between the two
different approaches, the concentrations of antibody solutions
were fixed (Figure 3, A, black line). We believe that the step-
wisely increase of the SPR response during the immobilization
Figure 4. (A) Real-time measured SPR response for different concentrations of human apoE (down, normal and up-regulated): faster kinetics corresponds to
higher concentrations. (B) Real-time measured SPR response for different concentrations of human apoE consecutively injected on the same sensor: the slope of
the curve increases when higher concentrations are dosed.
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may be due to the binding of clusters of cross-linked anti-
bodies with the surface.
The SPR shift for the cross-linking approach gives a surface
coverage for the antibodies of approximately 305 ng/cm2, twice
that obtained by the biotin–neutravidin approach, as previously
mentioned (see Biotin–neutravidin immobilization). This result
could be easily explained by the cross-linking of the antibodies
building up in a multilayer fashion, the only limit to this process
being the life-time of the semi-stable amine-reactive NHS-ester,
which at pH 7.4 is few hours.18
However, cross-linking of antibodies reduces their reactiv-
ity toward bait proteins and also, in the case of thick
multilayer reduces chances for the protein to be captured
within the probe depth.
apoE sensing
Figure 3, B shows the real-time measured SPR response for
the two functionalization approaches upon the exposure of a
30-μg/mL solution (physiological range of regulation for
humans29) of human apoE into the sensing region, flowed with
a rate of 1 μL/min. The black line represents the SPR for the
cross-linking approach, and no significative red shift is observed,
meaning that the amount of apoE captured by the IgG is not
detectable by our system. The blue line represents the SPR
response for the case where the antibodies were linked
accordingly to the biotin–neutravidin strategy. The binding
kinetics obtained shows that 30 μg/mL apoE can be detected real
time in a relatively short time (~1 h). Considering the small flow
rate employed in the experiments, we expect to be in mass-
transport limited conditions, resulting in slower binding kinetics
respect to value reported in literature for typical specific binding
between molecules.30Note that in the biotin–neutravidin strategy the amount of
IgGs immobilized on the sensor is half of that linked using
the cross-linking approach, which demonstrates the impor-
tance of the order and orientation of the antibodies on the
sensor surface. A negative control was performed in order to
assure the specificity of the measure, exposing the protein
carcino-embryonic antigen (CEA), and no shift of the SPR
signal was observed (see inset in Figure 3, B).
Assuming that apoE has the same refractive index and bulk
density as its antibodies and assuming that in the steady state
each antibody binds two apoE proteins, we would expect the
SPR response to be equivalent to a 39×2 kDa protein. Noting that
the SPR shift for antibodies (which have a molecular weight of
150 kDa) is about 1.2 nm, and considering the case where apoE
binds specifically to each IgG site available, a maximum shift of
0.6 nm would be expected. Therefore, we can estimate from the
SPR response that after 1 h roughly 25% of the IgG binding sites
are occupied.
Figure 3, B demonstrates the effect of different strategies to
immobilize antibodies on the surface, and demonstrates that the
biotin–neutravidin approach presented in this work, which
enables improvements in the order and orientation of the IgGs,
leads to significant performance improvements in the sensor.
apoE regulation
A point-of-care biosensor should be able not only to detect
specifically one or more biomarkers, but it also must be able to
provide quantitative information about their regulation, as in the
typical samples biomarkers are present in physiological
conditions. For example, in the case of apoE the normal
regulation range in humans is 23–49 μg/mL,29 with higher
concentrations having been shown to be related to gastric cancer,
where typically a 2.5-fold increase of apoE in serum occurs in
556 B. Sciacca et al / Nanomedicine: Nanotechnology, Biology, and Medicine 9 (2013) 550–557affected patients (unpublished results). The quantification of the
amount of analyte present in the solution is not trivial, as it
requires calibration of the real-time sensor response to different
analyte concentrations.
The measured SPR response for different concentrations of
apoE is shown in Figure 4, A, where each curve represents the
binding kinetics of apoE in a single experiment. Three different
concentrations are reported: 20, 30 and 90 μg/mL, respectively
representing the down-regulated, normally regulated and up-
regulated conditions for apoE in humans. From the data
represented in Figure 4, A a discernment between different
regulations is possible in a relatively short time frame (~1 h),
and in particular for the case of the up-regulated condition, which
could contribute to a gastric cancer diagnosis. The missing data
point in Figure 4, A, for the case of up-regulated apoE is due to a
false reading caused by an air bubble passing thought the sensor
microfluidic flow cell.
According to the LOD estimated above and from the result
shown in Figure 4, A, we believe the sensor to be able to detect a
minimum apoE concentration between 5 and 10 μg/mL.
Although this is not as sensitive as ELISA analysis (see technical
notes from Mabtech about “ELISA for Human Apolipoprotein
E,” http://www.mabtech.com), we designed the sensor to work
for the biological relevant regulation range for the biomarker.
Figure 4,B shows themeasured SPR response, where different
human apoE concentrations are exposed to the sensor within the
same experiment, consecutively. The figure clearly demonstrates
the different binding rapidity when higher concentrations of apoE
are dosed, consistent with the data shown in Figure 4, A.
Furthermore, Figure 4, B which shows the kinetic of the SPR
signal when increasing concentration of the apoE is injected into
the sensor flow cell, demonstrates that the discrimination of
different concentrations of apoE can be performed within a single
experiment. These results show that the analysis of the regulation
of human apoE solutions is possible with the platform here
proposed, and particularly that this system works for apoE
concentrations that are clinically relevant in discriminating gastric
cancer patients from unaffected individuals.Discussion
In summary, a novel radiative-SPR platform, which was
previously demonstrated for use in the rapid detection of the
influenza A virus, is here proven to be effective for the detection
in a relatively short timeframe (~1 h) of proteins with relatively
low molecular weights in clinically relevant concentrations, as
human apoE, that was discovered as a potential biomarker for
gastric cancer in a proteomics study based on a genetically
distinct mouse model and translated into humans. The
importance of the surface functionalization approach is also
demonstrated, showing that the antibody orientation plays a
predominant role in the capture efficiency and consequently on
the sensor ability to detect this small proteins. Although the
quantity of antibodies immobilized with the biotin–neutravidin
approach is half of that immobilized with the cross-linking
strategy, only the biotin–neutravidin approach enabled the
detection of a 30 μg/mL solution of apoE. This approach mayoffer significant advantages compared to protein A surface
functionalization strategies such as a reduced reactivity with free
IgG antibodies in clinical samples. We believe this strategy to be
of general interest and not only related to this scattered surface
plasmon based architecture. In fact, the biotin–neutravidin
functionalization approach could be used with any biosensor,
regardless of the transduction mechanism involved. The
advantages are a better orientation of the immobilized antibodies
onto the sensor's surface and the possibility of controlling the
resulting surface density of immobilized antibodies.
Furthermore, the system has proven efficient also in
quantifying the regulation of human apoE, being able to discern
between physiological and gastric cancer conditions in a short
timeframe, and has demonstrated to hold the needed qualities for
point-of-care diagnostics.
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